Letrozole and Cabergoline Co-administration in the Early Luteal Phase for Prevention of OHSS in a High Risk Patient Undergoing Ovarian Stimulation for IVF

Fatemi HM¹, Kyrou D^2*, Papanikolaou EG³, Al Buarki H¹ and Garcia Velasco J⁴

¹Vrije Universiteit Brussel, Centre for reproductive medicine/RHH Kuwait, Laarbeeklaan 101, 1090 Brussels, Belgium

²Unit for Human Reproduction, Department of Obstetrics and Gynaecology, Medical School, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Thessaloniki 54603, Greece

³Human Reproduction & Genetics Foundation, Adrianoupoleos 6, 55133 Kalamaria, Thessaloniki, Greece

⁴IVI-Madrid, Rey Juan Carlos University, Madrid, Spain

^*Corresponding Author: Kyrou D, Unit for Human Reproduction, Department of Obstetrics and Gynaecology, Medical School, Papageorgiou General Hospital, Aristotle University of Thessaloniki, Nea Efkarpia Peripheral Road, Thessaloniki 54603, Greece Email: